acetazolamide has been researched along with Pseudotumor Cerebri in 222 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
Excerpt | Relevance | Reference |
---|---|---|
" Currently, no standardized treatment guidelines are available and the current management focuses on weight loss and acetazolamide use." | 9.41 | Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review. ( Goyal, A; Zarroli, K, 2023) |
"Patients underwent weight loss and treatment with acetazolamide during a 24-week period." | 9.08 | The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri) ( Johnson, LN; Krohel, GB; Madsen, RW; March, GA, 1998) |
" The information regarding fetal effects of acetazolamide use during pregnancy and lactation is sparse." | 9.05 | Brief report: Metabolic acidosis in newborn infants following maternal use of acetazolamide during pregnancy. ( Hussain, N; Ibrahim, A, 2020) |
"Although laboratory finding of metabolic acidosis is common among patients with idiopathic intracranial hypertension treated with acetazolamide, it is not correlated with clinics." | 8.84 | The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. ( Barnoy, N; Bulkowstein, Y; Gilboa, T; Nitzan-Luques, A; Reif, S; Schnapp, A; Volovesky, O, 2024) |
"Acetazolamide (ACZ) lowers intraocular pressure (IOP), acutely in normal eyes and both acutely and chronically in eyes with glaucoma, and cerebrospinal fluid pressure (CSFp), chronically in patients with idiopathic intracranial hypertension (IIH)." | 7.91 | The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients. ( Banik, R; Garvin, MK; Kupersmith, MJ; Wang, JK, 2019) |
" Acetazolamide is widely used as the initial treatment option; however, previously published evidence suggests that this drug may also increase the risk of nephrolithiasis." | 7.83 | Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients. ( Au, JN; Huisingh, C; McGwin, G; Tanne, E; Waslo, CS, 2016) |
"There is no convincing evidence for an adverse effect for acetazolamide use in human pregnancy, even when prescribed prior to the 13th week of gestation." | 7.79 | The use of acetazolamide during pregnancy in intracranial hypertension patients. ( Falardeau, J; Golden, S; Lobb, BM; Maxfield, SD; Tanne, E, 2013) |
"To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH)." | 7.73 | The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. ( Capozzoli, T; Falardeau, J; Kardon, RH; Lee, AG; Pless, M; Wall, M, 2005) |
"To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease." | 7.71 | Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. ( Arnaud, B; Greenfield, DS; Harris, A; Pageaux, GP; Veyrac, M; Villain, MA, 2002) |
"To describe a case of pseudotumor cerebri associated with the administration of intermediate-dose cytarabine." | 7.70 | Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. ( Fort, JA; Smith, LD, 1999) |
"The purpose of this study was to investigate the efficacy of combined therapy with acetazolamide and furosemide in normalizing intracranial pressure in children with pseudotumor cerebri." | 7.69 | Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. ( Schoeman, JF, 1994) |
"We treated four patients who had acute, severe visual loss associated with pseudotumor cerebri with intravenous methylprednisolone (250 mg four times per day) for five days followed by an oral taper, in combination with acetazolamide and ranitidine." | 7.69 | High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. ( Glaser, JS; Liu, GT; Schatz, NJ, 1994) |
"Treatment with acetazolamide for pseudotumor cerebri (PTC) in a renal transplant patient led to an acute, but reversible deterioration in renal function." | 7.68 | Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri. ( Chagnac, A; Floru, S; Gafter, U; Korzets, A; Zevin, D, 1993) |
"Acetazolamide is a carbonic anhydrase inhibitor that is used to treat idiopathic intracranial hypertension, glaucoma, and epilepsy." | 5.43 | Possible association between acetazolamide administration during pregnancy and multiple congenital malformations. ( Al-Jobair, AM; Al-Saleem, AI, 2016) |
" Currently, no standardized treatment guidelines are available and the current management focuses on weight loss and acetazolamide use." | 5.41 | Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review. ( Goyal, A; Zarroli, K, 2023) |
"Frisén score fails to reflect the photographic area and OCT volume of papilledema after treatment with acetazolamide." | 5.27 | The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension. ( Blanchard, LM; Feldon, SE; Fischer, WS; Hollar, RA; Sheils, CR, 2018) |
" The Idiopathic Intracranial Hypertension Treatment Trial, a large, randomized, collaborative clinical trial, evaluated the efficacy of acetazolamide with weight loss versus placebo with weight loss in participants." | 5.22 | Pseudotumor cerebri: What We Have Learned from the Idiopathic Intracranial Hypertension Treatment Trial. ( Johnson, LN; Johnson, MA; Krohel, GB; Thakore, RV, 2016) |
"To assess treatment efficacy using spectral-domain (SD) optical coherence tomography (OCT) measurements of papilledema in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), which evaluated the effects of acetazolamide and weight management and of placebo and weight management in eyes with mild visual loss." | 5.20 | Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. ( , 2015) |
" The Idiopathic Intracranial Hypertension Treatment Trial was an adult, multicenter study that examined the use of acetazolamide and weight loss on the course of PIH." | 5.12 | Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases. ( Aylward, SC; Brun, BN, 2021) |
"Patients underwent weight loss and treatment with acetazolamide during a 24-week period." | 5.08 | The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri) ( Johnson, LN; Krohel, GB; Madsen, RW; March, GA, 1998) |
" The information regarding fetal effects of acetazolamide use during pregnancy and lactation is sparse." | 5.05 | Brief report: Metabolic acidosis in newborn infants following maternal use of acetazolamide during pregnancy. ( Hussain, N; Ibrahim, A, 2020) |
" Treatment options are serial lumbar punctures combined with body weight reduction as well as medication with carbonic anhydrase inhibitors, such as acetazolamide and topiramate or diuretic therapy with furosemide." | 4.91 | [Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension]. ( Nacimiento, W; Willenborg, KD, 2015) |
"Although laboratory finding of metabolic acidosis is common among patients with idiopathic intracranial hypertension treated with acetazolamide, it is not correlated with clinics." | 4.84 | The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension. ( Barnoy, N; Bulkowstein, Y; Gilboa, T; Nitzan-Luques, A; Reif, S; Schnapp, A; Volovesky, O, 2024) |
"This open-label, single-center pilot study suggests that GLP-1-RAs are an effective and safe treatment option for achieving significant weight loss with a favorable effect on headache, leading to reduced acetazolamide dosage in pwIIH." | 4.31 | Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension. ( Bsteh, G; Harreiter, J; Itariu, B; Krajnc, N; Macher, S; Marik, W; Michl, M; Novak, K; Pemp, B; Wöber, C, 2023) |
"VSS is an effective and safe procedure resulting in significant improvement of headaches, visual impairment, dizziness, and tinnitus, acetazolamide and topiramate usage were lower after VSS in patients with IIH." | 4.12 | Dural Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A National Database Study of 541 Patients. ( Kan, P; Lall, R; Nia, AM; Srinivasan, VM, 2022) |
"Acetazolamide (ACZ) lowers intraocular pressure (IOP), acutely in normal eyes and both acutely and chronically in eyes with glaucoma, and cerebrospinal fluid pressure (CSFp), chronically in patients with idiopathic intracranial hypertension (IIH)." | 3.91 | The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients. ( Banik, R; Garvin, MK; Kupersmith, MJ; Wang, JK, 2019) |
" The most common symptom was headache (69%) and acetazolamide was the most used medication (69%)." | 3.88 | Pseudotumor cerebri in childhood and adolescence: data from a specialized service. ( Balbi, GGM; Fraga, MM; Len, CA; Matas, SL; Sousa, IO; Terreri, MT, 2018) |
" Acetazolamide is widely used as the initial treatment option; however, previously published evidence suggests that this drug may also increase the risk of nephrolithiasis." | 3.83 | Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients. ( Au, JN; Huisingh, C; McGwin, G; Tanne, E; Waslo, CS, 2016) |
" Following lumbar puncture with opening pressure of 350 mmHg, a diagnosis of pseudotumor cerebri was made and treatment with acetazolamide was started." | 3.79 | Unilateral papilledema in pseudotumor cerebri. ( Brosh, K; Strassman, I, 2013) |
"There is no convincing evidence for an adverse effect for acetazolamide use in human pregnancy, even when prescribed prior to the 13th week of gestation." | 3.79 | The use of acetazolamide during pregnancy in intracranial hypertension patients. ( Falardeau, J; Golden, S; Lobb, BM; Maxfield, SD; Tanne, E, 2013) |
" The authors present 2 patients with Alagille syndrome who, before the age of 3 years old, developed idiopathic intracranial hypertension with documented increased intracranial pressure by lumbar puncture and papilledema, which was responsive to acetazolamide." | 3.76 | Idiopathic intracranial hypertension in two patients with Alagille syndrome. ( Furuya, KN; Mouzaki, M; Nichter, C; Qureshi, M; Rountree, B, 2010) |
" The diagnosis of a pseudotumor cerebri, secondary to Behçet disease was raised and the patient was treated with colchicine and acetazolamide." | 3.76 | [Pseudotumor cerebri secondary to Behçet disease. Report of one case]. ( Castiglione, E; Durán, J; Eymin, G; Gutiérrez, MA; Jacobelli, S; Jurado, M; Valenzuela, R, 2010) |
" One child with PTC demonstrated improvement in visual acuity and optic nerve appearance after acetazolamide and weight loss therapy." | 3.74 | Pseudotumor cerebri in children with Down syndrome. ( Bradfield, YS; Esmaili, N, 2007) |
"To describe the pregnancy outcomes after the use of acetazolamide in pregnant patients with idiopathic intracranial hypertension (IIH)." | 3.73 | The use of acetazolamide in idiopathic intracranial hypertension during pregnancy. ( Capozzoli, T; Falardeau, J; Kardon, RH; Lee, AG; Pless, M; Wall, M, 2005) |
" This was managed non-operatively with lumbar cerebrospinal fluid tap, weight reduction, nicotinic acid and acetazolamide." | 3.73 | Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness. ( Idowu, OE; Malomo, AO; Nwaorgu, OG; Oluleye, TS; Shokunbi, MT, 2006) |
"To describe the hemodynamic effect of oral acetazolamide administration on ocular perfusion in a patient with pseudotumor cerebri associated with Crohn disease." | 3.71 | Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease. ( Arnaud, B; Greenfield, DS; Harris, A; Pageaux, GP; Veyrac, M; Villain, MA, 2002) |
"Tetracyclines have long been recognized as a cause of pseudotumor cerebri in adults, but the role of tetracyclines in the pediatric age group has not been well characterized in the literature and there have been few reported cases." | 3.70 | Pediatric tetracycline-induced pseudotumor cerbri. ( Buncic, JR; Quinn, AG; Singer, SB, 1999) |
"To describe a case of pseudotumor cerebri associated with the administration of intermediate-dose cytarabine." | 3.70 | Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl. ( Fort, JA; Smith, LD, 1999) |
"Idiopathic intracranial hypertension (IIH, pseudotumor cerebri) was diagnosed in 4 patients who had been treated with tetracycline." | 3.69 | [Idiopathic intracranial hypertension and tetracycline]. ( Schwartz, M; Sharf, B; Sierpinski-Barth, J; Weller, B, 1994) |
"The purpose of this study was to investigate the efficacy of combined therapy with acetazolamide and furosemide in normalizing intracranial pressure in children with pseudotumor cerebri." | 3.69 | Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. ( Schoeman, JF, 1994) |
"We treated four patients who had acute, severe visual loss associated with pseudotumor cerebri with intravenous methylprednisolone (250 mg four times per day) for five days followed by an oral taper, in combination with acetazolamide and ranitidine." | 3.69 | High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. ( Glaser, JS; Liu, GT; Schatz, NJ, 1994) |
"Treatment with acetazolamide for pseudotumor cerebri (PTC) in a renal transplant patient led to an acute, but reversible deterioration in renal function." | 3.68 | Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri. ( Chagnac, A; Floru, S; Gafter, U; Korzets, A; Zevin, D, 1993) |
" The course was complicated by superior sagittal sinus thrombosis which we believe to be related to acetazolamide therapy." | 3.66 | Benign intracranial hypertension, monoclonal gammopathy, and superior sagittal sinus thrombosis. ( Davis, CE; Gilman, JK; Hibri, N; Smith, CH, 1983) |
"In the IIHTT, subjects were randomly assigned to placebo-plus-diet or maximally tolerated dosage of acetazolamide-plus-diet." | 2.84 | The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12. ( Auinger, P; Kupersmith, MJ; Moss, EA; Moss, HE; Thurtell, MJ; Wall, M, 2017) |
"To examine the tolerability and adverse events reported in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT)." | 2.82 | Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial. ( Friedman, DI; Irrcher, I; McDermott, MP; Patel, AD; ten Hove, MW; Wall, M, 2016) |
"Acetazolamide is a common treatment but has never been examined in a randomised controlled trial." | 2.76 | A randomised controlled trial of treatment for idiopathic intracranial hypertension. ( Ball, AK; Burdon, MA; Clarke, CE; Davies, MB; Furmston, A; Howell, S; Howman, A; Jacks, AS; Lawden, M; Matthews, T; Sharrack, B; Sinclair, AJ; Sivaguru, A; Wheatley, K, 2011) |
"Prominent weight loss was recorded in the topiramate group." | 2.73 | Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. ( Akyürekli, O; Celebisoy, N; Gökçay, F; Sirin, H, 2007) |
"Parents of school-age children with idiopathic intracranial hypertension were asked to fill out a questionnaire and to rank the child's behavioral patterns before and after the diagnosis and treatment of the disease." | 2.73 | Behavioral disorders in children with idiopathic intracranial hypertension. ( Leiba, H; Margalit, D; Parness-Yossifon, R; Pollack, A, 2008) |
"The headache associated with idiopathic intracranial hypertension frequently has a migrainous phenotype." | 2.72 | Diagnosis and treatment of idiopathic intracranial hypertension. ( Hoffmann, J; Raoof, N, 2021) |
"The acetazolamide (AZA) test is a well-accepted method for measuring the vascular reactivity of the cerebral arteries." | 2.70 | Cerebrovascular reactivity in patients under long-term acetazolamide treatment. ( Gadot, N; Kesler, A; Lampl, Y; Lorberboyn, M; Sadeh, M, 2002) |
"Symptomatic treatment of headache is recommended." | 2.61 | [Idiopathic intracranial hypertension - Swedish consensus guidelines]. ( Gustavsson, B; Hellgren, K; Lundvall, M; Nilsson Remahl, I; Söderman, M; Sundholm, A; Träisk, F, 2019) |
"Idiopathic intracranial hypertension is a vision-threatening disorder that predominantly affects obese women of childbearing age." | 2.58 | An update of idiopathic intracranial hypertension. ( Cestari, DM; Madriz Peralta, G, 2018) |
"Prior to the IIHTT, clinicians managed idiopathic intracranial hypertension based on data from small, unmasked trials, expert opinion, and clinical experience." | 2.55 | The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes. ( Friedman, DI; Smith, SV, 2017) |
"Idiopathic intracranial hypertension is characterized by signs and symptoms of raised intracranial pressure with no established pathogenesis." | 2.55 | [Idiopathic intracranial hypertension]. ( Bäuerle, J; Egger, K; Harloff, A, 2017) |
"Obesity is an important risk factor for primary and secondary PTC in post-pubertal children." | 2.53 | Pediatric pseudotumor cerebri. ( Phillips, PH; Rook, BS, 2016) |
"In high-pressure hydrocephalus, the volume of the CSF is increased, resulting either from increased production or reduced absorption." | 2.48 | [Headache from increased cerebrospinal fluid pressure]. ( Göbel, C; Göbel, H; Heinze, A, 2012) |
"Some theories - such as the dural sinus stenosis theory - seem to ignore the relationship with weight gain; others have proposed a direct link between obesity and raised intracranial pressure through a specific fat distribution in the body; others through the production of lipokines; and yet others have suggested a converse causation with raised intracranial pressure giving rise to obesity." | 2.47 | The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension. ( Fraser, C; Plant, GT, 2011) |
"Although the demographics of pediatric idiopathic intracranial hypertension have been well described, the best approaches to its management are less well defined." | 2.44 | Advances in evaluation and management of pediatric idiopathic intracranial hypertension. ( Hutcheson, KA; Wolf, A, 2008) |
"Pseudotumor cerebri is an unusual presentation of Lyme disease." | 2.40 | Pseudotumor cerebri in Lyme disease: a case report and literature review. ( Kan, L; Maytal, J; Sood, SK, 1998) |
"This retrospective single-center study evaluated the change in required dosage of acetazolamide and topiramate before and after dural venous sinus stent placement (VSSP) for idiopathic intracranial hypertension (IIH)." | 1.91 | Dural Venous Sinus Stent Placement Reduces Dosage Requirements for Carbonic Anhydrase Inhibitors in Patients with Idiopathic Intracranial Hypertension. ( Martin, J; Sanborn, MR, 2023) |
"Acetazolamide therapy was started, and papilledema in both eyes resolved within weeks." | 1.72 | Recurrent Intracranial Hypertension in a Toddler with Graves' Disease. ( de Bruin, C; Notting, IC; Peeters-Scholte, CMPCD; Vuijk, FA, 2022) |
"Although weight gain is expected in pregnancy, excessive weight gain may exacerbate IIH and increase maternal and fetal complications; evidence-based recommendations for non-IIH pregnancies may help in guiding optimal gestational weight gain." | 1.72 | Managing idiopathic intracranial hypertension in pregnancy: practical advice. ( Abbott, S; Mollan, SP; Sinclair, AJ; Tahrani, AA; Thaller, M; Wakerley, BR, 2022) |
"We sought to characterize this bias for idiopathic intracranial hypertension (IIH) and evaluate strategies to reduce it." | 1.72 | Predictive Value of International Classification of Diseases Codes for Idiopathic Intracranial Hypertension in a University Health System. ( Khushzad, F; Kumar, R; Moss, HE; Muminovic, I, 2022) |
" IOPs preoperatively and postoperatively were recorded along with the acetazolamide dosage and whether there was evidence of posterior scleral or globe indentation on preoperative MRI." | 1.72 | The Effect of Optic Nerve Sheath Fenestration on Intraocular Pressure in Patients With Idiopathic Intracranial Hypertension. ( Ford, WC; Mancini, R; Mullen, M; Scofield-Kaplan, SM, 2022) |
"A robust predictor of visual outcome in idiopathic intracranial hypertension (IIH) would be useful in management, but there is limited information on this point." | 1.51 | Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome. ( Cornblath, WT; De Lott, L; Mikkilineni, S; Trobe, JD, 2019) |
"He had bilateral sixth nerve palsy worse on the left eye and bilateral hypometric saccade." | 1.51 | Co-occurrence of acute ophthalmoplegia (without ataxia) and idiopathic intracranial hypertension. ( Mohamad, NF; Singh, S; Yeak, J; Zahari, M, 2019) |
"Patients with idiopathic intracranial hypertension commonly present with a headache, transient visual obscurations, and intracranial noises with some cranial nerves occasionally involved, most commonly CN VI." | 1.51 | Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report. ( Berry, B; Ghannam, M; Ghazaleh, D; Samara, A, 2019) |
"Recurrences were noted in 23%." | 1.51 | Idiopathic intracranial hypertension: Are there predictors for visual outcome or recurrences? ( Celebisoy, N; Gokcay, F; Kisabay, A; Tata, G, 2019) |
"Acetazolamide treatment is effective in most cases, and it represents a viable alternative to repeated LP." | 1.51 | Pseudotumour cerebri in children: Aetiology, clinical features, and progression. ( Aguilera Albesa, S; Azcona Ganuza, G; Gembero Esarte, E; Iridoy Zulet, M; Mosquera Gorostidi, A; Yoldi Petri, ME, 2019) |
"Purpose/Aim: Pseudotumor cerebri or idiopathic intracranial hypertension (IIH) is characterized by increased intracranial pressure of unknown etiology." | 1.46 | A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography. ( Abraham, MG; Arnold, PM; Camarata, PJ; Peterson, JC; Smith, KA; Whittaker, TJ, 2017) |
"Acetazolamide is a carbonic anhydrase inhibitor that is used to treat idiopathic intracranial hypertension, glaucoma, and epilepsy." | 1.43 | Possible association between acetazolamide administration during pregnancy and multiple congenital malformations. ( Al-Jobair, AM; Al-Saleem, AI, 2016) |
"Pseudotumor cerebri is an idiopathic increase in intracranial pressure, which commonly affects obese women of fertile age." | 1.42 | [Intracranial hypertension and jugular vein thrombosis]. ( Helbig, H; Konrad, J; Oberacher-Velten, I; Vogt, R, 2015) |
"The patient was diagnosed with idiopathic intracranial hypertension and treated with azetazolamide." | 1.39 | [Idiopathic intracranial hypertension is a rare cause of headache in children]. ( Hansen, JK; Møller, HU; Viuff, AC, 2013) |
"Acetazolamide was the drug of choice, with relatively low dosages used." | 1.39 | Pseudotumor cerebri in childhood and adolescence -- results of a Germany-wide ESPED-survey. ( Distelmaier, F; Mayatepek, E; Tibussek, D; von Kries, R, 2013) |
"Pseudotumor cerebri or idiopathic intracranial hypertension is characterized by normal spinal fluid composition and increased intracranial pressure in the absence of a space-occupying lesion." | 1.39 | Viral-induced intracranial hypertension mimicking pseudotumor cerebri. ( Kassis, I; Kra-Oz, Z; Ravid, S; Shachor-Meyouhas, Y; Shahar, E, 2013) |
"Pseudotumor cerebri is an avoidable cause of visual loss, both in adults and children." | 1.39 | Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. ( Canpolat, M; Doğan, H; Gümüş, H; Karaküçük, S; Kumandaş, S; Per, H; Poyrazoğlu, HG; Yıkılmaz, A, 2013) |
"A 14 year-old Caucasian boy with idiopathic intracranial hypertension (IIH) presented with blurred vision in his left eye." | 1.39 | Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension. ( Kwan, AS; Lee, IJ; Maccheron, LJ, 2013) |
"Acetazolamide was used as the first drug and was effective in only 4 patients who had no underlying cause." | 1.38 | Pseudotumour cerebri in children: etiological, clinical features and treatment modalities. ( Hacifazlioglu Eldes, N; Yilmaz, Y, 2012) |
"The patient was diagnosed as having idiopathic intracranial hypertension and treated with oral acetazolamide." | 1.37 | A case of pediatric idiopathic intracranial hypertension presenting with divergence insufficiency. ( Kang, HM; Kim, HY, 2011) |
"Pseudotumor cerebri has only been described after successful surgery for Cushing's disease (CD) in case reports." | 1.36 | Pseudotumor cerebri after surgical remission of Cushing's disease. ( Keil, M; Kiehna, EN; Lodish, M; Oldfield, EH; Stratakis, C, 2010) |
"Along with the progression, bilateral 6th nerve palsy, impairment of visual acuity and bilateral papilledema appeared." | 1.36 | [Benign but not harmless intracranial hypertension: a case report]. ( Bonnin, N; Chazal, J; Chiambaretta, F; Dalens, H; Deméocq, F; Duclos, C; Kanold, J; Lacombe, P; Merlin, E; Viorel, A, 2010) |
"Treatment with acetazolamide reduced the cerebrospinal pressure." | 1.35 | [Idiopathic intracranial hypertension without headache detected during a routine health check]. ( Niino, M; Sakushima, K; Sasaki, H; Tsuji, S; Yabe, I, 2008) |
"For a diagnosis of idiopathic intracranial hypertension (IIH), she was treated with acetazolamide and methylprednisolone, but vision worsened, so she underwent bilateral optic sheath fenestration (ONSF)." | 1.35 | Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. ( Siatkowski, RM; Wilkes, BN, 2009) |
"Although a stenosis of the transverse sinus has been observed in many IIH patients, the role this feature plays in IIH is in dispute." | 1.34 | Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study. ( Hamschin, B; Lakin, WD; Penar, PL; Previte, M; Stevens, SA; Thakore, NJ, 2007) |
"Facial paralysis is an uncommon sequela of IIH." | 1.34 | Facial palsy and fallopian canal expansion associated with idiopathic intracranial hypertension. ( Brackmann, DE; Doherty, JK, 2007) |
"However, prompt diagnosis of idiopathic intracranial hypertension and initiation of medical therapy lead to improved symptoms and restored vision." | 1.33 | Idiopathic intracranial hypertension and sickle cell disease: two case reports. ( Discepola, M; Segal, L, 2005) |
"Of 1140 cases of idiopathic intracranial hypertension, six patients had juxtapapillary SRNVM." | 1.33 | Subretinal neovascular membrane in idiopathic intracranial hypertension. ( Boldt, HC; Kardon, RH; Lee, AG; Wall, M; Wendel, L, 2006) |
"Although papilledema is described in various anemias, only one case of PTC with idiopathic aplastic anemia has been reported in the English literature." | 1.32 | Pseudotumor cerebri in idiopathic aplastic anemia. ( Nazir, SA; Siatkowski, RM, 2003) |
"Acetazolamide dosage was given while the patients underwent an immunosuppressive regimen." | 1.31 | Pseudotumor cerebri in two adolescents with acquired aplastic anemia. ( Bhakta, M; Helton, K; Jeng, MR; Rieman, M; Wang, WC, 2002) |
"Minocycline and obesity are recognized as precipitating factors in pseudotumor cerebri syndrome." | 1.31 | [Bilateral papilledema in young women: two case reports of benign intracranial hypertension?]. ( Cochener, B; Colin, J; Kling, F, 2002) |
"Cover test revealed an intermittent esotropia at distance, with full ocular motilities." | 1.31 | Pseudotumor cerebri in a pre-pubescent child--case report. ( Langford, CM, 2002) |
"Complications of otitis media are relatively infrequent, especially since the introduction of effective antimicrobial agents and specific surgical techniques." | 1.31 | [Sigmoid sinus thrombosis as a complication of otitis media]. ( Ayala Curiel , J; Gracia Remiro , R; Herrera Martín , M; Hortelano López , M; Jiménez Moya , AI; Romero Escos , D; Santana Rodríguez , C, 2000) |
"After resolution of the optic disc edema, these three patients were maintained on CPAP but discontinued acetazolamide." | 1.31 | Sleep apnea and intracranial hypertension in men. ( Eggenberger, E; Golnik, K; Kardon, R; Lee, AG; Wall, M; Yedavally, S, 2002) |
"In comparison with patients who have idiopathic intracranial hypertension, our small series of 14 patients diagnosed after the age of 44 years were more often men, were less often obese, were less symptomatic, and had identifiable causes of intracranial hypertension in a substantial minority (29%)." | 1.31 | Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria. ( Bandyopadhyay, S; Jacobson, DM, 2002) |
"Presenting symptoms of idiopathic intracranial hypertension are known to vary with age." | 1.31 | Asymptomatic idiopathic intracranial hypertension in young children. ( Weig, SG, 2002) |
"Pseudotumor cerebri is a clinical syndrome characterized by increased intracranial pressure in the absence of an intracranial tumor." | 1.30 | Pseudotumor cerebri as a presenting symptom of acute sinusitis in a child. ( Keren, T; Lahat, E, 1998) |
"A 6-year-old girl developed symptoms of benign intracranial hypertension following reduction of oral corticosteroid therapy." | 1.30 | [Benign intracranial hypertension: an unrecognized complication of corticosteroid therapy]. ( Bader-Meunier, B; Dommergues, JP; Lorrot, M; Sébire, G, 1999) |
"To report the features of idiopathic intracranial hypertension in prepubertal children, with emphasis on presentation, treatment, and outcome." | 1.30 | Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. ( Borchert, MS; Cinciripini, GS; Donahue, S, 1999) |
"Dural sinus thrombosis is a rare and potentially serious complication of suboccipital craniotomy and translabyrinthine craniectomy." | 1.30 | Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccipital craniotomy and translabyrinthine craniectomy. ( Keiper, GL; Sherman, JD; Tew, JM; Tomsick, TA, 1999) |
"Papilledema from benign intracranial hypertension can cause severe loss of visual acuity and visual field, with an optic neuropathy." | 1.30 | [Intra-orbital decompression of the optic nerve by opening the peri-optic meninges in the treatment of severe optic neuropathies complicating benign intracranial hypertension]. ( Adenis, JP; Arnaud, B; Candon, E; Frerebeau, P; Villain, M, 1999) |
"We report the occurrence of idiopathic intracranial hypertension in a patient treated with ofloxacin, a fluoroquinolone antimicrobial agent, for 16 months." | 1.29 | Idiopathic intracranial hypertension after ofloxacin treatment. ( Aimard, G; Croisile, B; Getenet, JC; Goudable, B; Grochowicki, M; Trillet, M; Vighetto, A, 1993) |
"We report two cases of idiopathic intracranial hypertension causing chronic daily headache with migrainous features in the absence of associated papilledema." | 1.29 | Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension. ( Huff, AL; Hupp, SL; Rothrock, JF, 1996) |
"In previous accounts of idiopathic intracranial hypertension in children, concomitant papilledema, visual symptoms and/or palsy of the sixth cranial nerve are described." | 1.29 | Idiopathic intracranial hypertension in a young child without visual symptoms or signs. ( Bello, L; Winner, P, 1996) |
"Pseudotumor cerebri is a central nervous disorder with elevated intracranial pressure that is most common among young obese women." | 1.28 | [Pseudotumor cerebri, clinical parameters and therapeutic modalities]. ( Blumer, B; Burde, RM; Killer, HE, 1992) |
" We deem the initial dosage of 16 mg Millicorten/day to be therapeutically effective and adequate." | 1.28 | [Pseudotumor cerebri in pregnancy]. ( Benz, J; Zeller, R, 1990) |
"No pregnancy was adversely affected, but symptoms of pseudotumor increased in 9 of 11 pregnancies." | 1.28 | Pseudotumor cerebri and pregnancy. ( Cefalo, RC; Katz, VL; Peterson, R, 1989) |
"After pseudotumor cerebri was diagnosed and the appropriate treatment begun, the papilledema disappeared, but the visual field defect persisted." | 1.27 | Permanent inferior binasal quadrantanopsia in pseudotumor cerebri. ( Nichelli, P; Penne, A, 1983) |
"Pseudotumor cerebri is characterized by increased intracranial pressure and papilledema, with an essentially normal neurologic examination." | 1.27 | Pseudotumor cerebri. ( Bowman, MA, 1987) |
"A review of the most recent 23 cases of benign intracranial hypertension (BIH), admitted to the War Memorial Children's Hospital in London, Ontario, provided a compendium of the clinical manifestations of this disorder in children and adolescents." | 1.27 | Spectrum of benign intracranial hypertension in children and adolescents. ( Amacher, AL; Spence, JD, 1985) |
"A series of 28 patients presenting with benign intracranial hypertension is reported." | 1.26 | Benign intracranial hypertension: clinical features and diagnosis using computed tomography and treatment. ( Uttley, D; Vassilouthis, J, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (8.56) | 18.7374 |
1990's | 38 (17.12) | 18.2507 |
2000's | 46 (20.72) | 29.6817 |
2010's | 99 (44.59) | 24.3611 |
2020's | 20 (9.01) | 2.80 |
Authors | Studies |
---|---|
Brun, BN | 1 |
Aylward, SC | 2 |
Vuijk, FA | 1 |
de Bruin, C | 1 |
Peeters-Scholte, CMPCD | 1 |
Notting, IC | 1 |
Thaller, M | 1 |
Wakerley, BR | 1 |
Abbott, S | 1 |
Tahrani, AA | 1 |
Mollan, SP | 2 |
Sinclair, AJ | 3 |
Khushzad, F | 1 |
Kumar, R | 1 |
Muminovic, I | 1 |
Moss, HE | 3 |
Mullen, M | 1 |
Scofield-Kaplan, SM | 1 |
Ford, WC | 1 |
Mancini, R | 1 |
Nia, AM | 1 |
Srinivasan, VM | 1 |
Lall, R | 1 |
Kan, P | 1 |
Souza, MNP | 1 |
Costa, BAL | 1 |
Santos, FRDR | 1 |
Fortini, I | 1 |
Price, M | 2 |
Hofman, PL | 2 |
Hsiao, K | 2 |
Jones, HF | 2 |
Tilak, AM | 1 |
Yang, LC | 1 |
Morgan, J | 1 |
Peña-Garcia, J | 1 |
Thompson, M | 1 |
Burleson, S | 1 |
Atkins, A | 1 |
Sheehan, D | 1 |
Cho, DY | 1 |
Woodworth, BA | 1 |
Grayson, JW | 1 |
Martin, J | 1 |
Sanborn, MR | 1 |
Güngör Tunçer, Ö | 1 |
Nalbantoglu, M | 1 |
Sengul, EA | 1 |
Baykan, B | 1 |
Krajnc, N | 1 |
Itariu, B | 1 |
Macher, S | 1 |
Marik, W | 1 |
Harreiter, J | 1 |
Michl, M | 1 |
Novak, K | 1 |
Wöber, C | 1 |
Pemp, B | 1 |
Bsteh, G | 1 |
Bulkowstein, Y | 1 |
Nitzan-Luques, A | 1 |
Schnapp, A | 1 |
Barnoy, N | 1 |
Reif, S | 2 |
Gilboa, T | 1 |
Volovesky, O | 1 |
Goyal, A | 1 |
Zarroli, K | 1 |
Batur Caglayan, HZ | 1 |
Ucar, M | 1 |
Hasanreisoglu, M | 1 |
Nazliel, B | 1 |
Tokgoz, N | 1 |
Costello, F | 1 |
Skolnik, K | 1 |
Sarna, J | 1 |
Varughese, R | 1 |
Ibrahim, A | 1 |
Hussain, N | 1 |
Ybarra, M | 1 |
Santos, TJD | 1 |
Queiroz, ES | 1 |
Rachid, L | 1 |
Franco, RR | 1 |
Cominato, L | 1 |
Moura, FC | 1 |
Velhote, MC | 1 |
Damiani, D | 1 |
Hollar, RA | 2 |
Fischer, WS | 2 |
Feldon, SE | 4 |
Daou, BJ | 1 |
Sweid, A | 1 |
Weinberg, JH | 1 |
Starke, RM | 1 |
Sergott, RC | 2 |
Doermann, AS | 1 |
Hauge, J | 1 |
Zanaty, M | 1 |
Chalouhi, N | 1 |
Gooch, R | 1 |
Herial, N | 1 |
Zarzour, H | 1 |
Jabbour, P | 1 |
Rosenwasser, RH | 1 |
Tjoumakaris, S | 1 |
Raoof, N | 1 |
Hoffmann, J | 1 |
Berkowitz, E | 1 |
Kopelman, Y | 1 |
Kadosh, D | 1 |
Carasso, S | 1 |
Tiosano, B | 1 |
Kesler, A | 5 |
Geva-Zatorsky, N | 1 |
Juhász, J | 1 |
Lindner, T | 1 |
Jansen, O | 1 |
Margraf, NG | 1 |
Rohr, A | 1 |
Kaufman, DI | 1 |
Friedman, DI | 5 |
Wang, JK | 3 |
Kardon, RH | 3 |
Ledolter, J | 1 |
Sibony, PA | 2 |
Kupersmith, MJ | 5 |
Garvin, MK | 2 |
Albrecht, P | 1 |
Blasberg, C | 1 |
Ringelstein, M | 1 |
Müller, AK | 1 |
Finis, D | 1 |
Guthoff, R | 1 |
Kadas, EM | 1 |
Lagreze, W | 1 |
Aktas, O | 1 |
Hartung, HP | 1 |
Paul, F | 1 |
Brandt, AU | 1 |
Methner, A | 1 |
Smith, SV | 1 |
Tovia, E | 1 |
Oren, A | 1 |
Mitelpunkt, A | 1 |
Fattal-Valevski, A | 1 |
Rossor, T | 1 |
Lim, M | 1 |
VanDenEshof, K | 1 |
Gringras, P | 1 |
Way, AL | 1 |
Raggi, A | 1 |
Grazzi, L | 1 |
Bianchi Marzoli, S | 1 |
Ciasca, P | 2 |
Chiapparini, L | 2 |
Erbetta, A | 2 |
Faragò, G | 1 |
Leonardi, M | 1 |
D'Amico, D | 2 |
Carlisle, A | 1 |
Kennedy, JL | 1 |
Chervinskiy, S | 1 |
Jones, SM | 1 |
Pesek, RD | 1 |
Park, H | 1 |
Lim, GY | 1 |
Eom, TH | 1 |
Sheils, CR | 1 |
Blanchard, LM | 1 |
Noda, M | 1 |
Sonoda, Y | 1 |
Takemoto, M | 1 |
Kira, R | 1 |
Mikkilineni, S | 1 |
Trobe, JD | 1 |
Cornblath, WT | 2 |
De Lott, L | 1 |
Madriz Peralta, G | 1 |
Cestari, DM | 1 |
Yeak, J | 1 |
Zahari, M | 1 |
Singh, S | 1 |
Mohamad, NF | 1 |
Umfress, AC | 1 |
Mawn, LA | 1 |
Joos, KM | 1 |
Balbi, GGM | 1 |
Matas, SL | 1 |
Len, CA | 1 |
Fraga, MM | 1 |
Sousa, IO | 1 |
Terreri, MT | 1 |
Banik, R | 1 |
Ozgonul, C | 1 |
Moinuddin, O | 1 |
Munie, M | 1 |
Lee, MS | 2 |
Bhatti, MT | 1 |
Landau, K | 2 |
Van Stavern, GP | 1 |
Mackay, DD | 1 |
Lebas, M | 1 |
DeLott, LB | 1 |
Besirli, CG | 1 |
Samara, A | 1 |
Ghazaleh, D | 1 |
Berry, B | 1 |
Ghannam, M | 1 |
Tata, G | 1 |
Kisabay, A | 1 |
Gokcay, F | 2 |
Celebisoy, N | 2 |
Sundholm, A | 1 |
Träisk, F | 1 |
Hellgren, K | 1 |
Lundvall, M | 1 |
Söderman, M | 1 |
Gustavsson, B | 1 |
Nilsson Remahl, I | 1 |
Mohammad, Y | 1 |
Aljafen, BN | 1 |
Alnafisah, MS | 1 |
Al-Hussain, FA | 1 |
Viuff, AC | 1 |
Hansen, JK | 1 |
Møller, HU | 1 |
Başar, Ö | 1 |
Başar, N | 1 |
Tuna, Y | 1 |
Yüksel, H | 1 |
Çoban, Ş | 1 |
Tibussek, D | 2 |
Distelmaier, F | 2 |
von Kries, R | 1 |
Mayatepek, E | 2 |
Kupferminc, M | 1 |
Brosh, K | 1 |
Strassman, I | 1 |
Ranganathan, S | 1 |
Lee, SH | 1 |
Checkver, A | 1 |
Sklar, E | 1 |
Lam, BL | 2 |
Danton, GH | 1 |
Alperin, N | 1 |
Ravid, S | 1 |
Shachor-Meyouhas, Y | 1 |
Shahar, E | 1 |
Kra-Oz, Z | 1 |
Kassis, I | 1 |
Aragonès, JM | 1 |
Alonso-Valdés, F | 1 |
McDermott, MP | 5 |
Kieburtz, K | 1 |
Kupersmith, M | 2 |
Stoutenburg, A | 1 |
Keltner, JL | 3 |
Schron, E | 1 |
Corbett, JJ | 2 |
Wall, M | 13 |
Curone, M | 1 |
Farago', G | 1 |
Bianchi-Marzoli, S | 1 |
Bussone, G | 1 |
Younes, S | 1 |
Aissi, M | 1 |
Chérif, Y | 1 |
Daoussi, N | 1 |
Boughammoura, A | 1 |
Frih Ayed, M | 1 |
Sfar, MH | 1 |
Jerbi, S | 1 |
Rodà, D | 1 |
Fons-Estupiña, MC | 1 |
Vidal-Santacana, M | 1 |
Mallery, RM | 1 |
Liu, GT | 3 |
Micieli, JA | 1 |
Al-Obthani, M | 1 |
Sundaram, AN | 1 |
Woolley, R | 1 |
McDermott, M | 1 |
Sun, LW | 1 |
Horton, JC | 1 |
Molobe, LT | 1 |
Shifa, J | 1 |
Silava, C | 1 |
Mojela, K | 1 |
Cainelli, F | 1 |
Vento, S | 1 |
Butori, P | 1 |
Jean-Charles, A | 1 |
Elana, G | 1 |
Merle, H | 1 |
Konrad, J | 1 |
Vogt, R | 1 |
Helbig, H | 1 |
Oberacher-Velten, I | 1 |
Supuran, CT | 1 |
Willenborg, KD | 1 |
Nacimiento, W | 1 |
ten Hove, MW | 1 |
Patel, AD | 1 |
Irrcher, I | 1 |
Au, JN | 1 |
Waslo, CS | 1 |
McGwin, G | 1 |
Huisingh, C | 1 |
Tanne, E | 2 |
Cello, KE | 2 |
Johnson, CA | 2 |
Mathew, M | 1 |
Salahuddin, A | 1 |
Mathew, NR | 1 |
Nandhagopal, R | 1 |
Smith, KA | 1 |
Peterson, JC | 1 |
Arnold, PM | 1 |
Camarata, PJ | 1 |
Whittaker, TJ | 1 |
Abraham, MG | 1 |
Beck, RW | 1 |
Zamba, KD | 1 |
Loo, KG | 1 |
Lim, SA | 1 |
Lim, IL | 1 |
Chan, DW | 1 |
Thakore, RV | 1 |
Johnson, MA | 1 |
Krohel, GB | 2 |
Johnson, LN | 2 |
Al-Saleem, AI | 1 |
Al-Jobair, AM | 1 |
Kwon, YJ | 1 |
Allen, JL | 1 |
McCormack, SE | 1 |
Rook, BS | 1 |
Phillips, PH | 1 |
Espino Barros Palau, A | 1 |
Morgan, ML | 1 |
Yalamanchili, S | 1 |
Lee, AG | 5 |
Abdelfatah, MA | 1 |
Bruce, BB | 2 |
Digre, KB | 2 |
Schron, EB | 1 |
Karenfort, M | 1 |
Harmsen, S | 1 |
Klee, D | 1 |
Libien, J | 1 |
Blaner, W | 1 |
Gao, S | 1 |
Liu, Y | 1 |
Corbett, J | 1 |
Garvin, M | 1 |
Kardon, R | 2 |
Mosquera Gorostidi, A | 1 |
Iridoy Zulet, M | 1 |
Azcona Ganuza, G | 1 |
Gembero Esarte, E | 1 |
Yoldi Petri, ME | 1 |
Aguilera Albesa, S | 1 |
Bäuerle, J | 1 |
Egger, K | 1 |
Harloff, A | 1 |
Gharib, A | 1 |
Khokhar, A | 1 |
Caperton, CV | 1 |
Hamadani, ST | 1 |
Thurtell, MJ | 2 |
Moss, EA | 1 |
Auinger, P | 1 |
Scott, NL | 1 |
Stryjewski, TP | 1 |
Rizzo, JF | 1 |
Marton, E | 1 |
Feletti, A | 1 |
Mazzucco, GM | 1 |
Longatti, P | 1 |
Kuzman, MR | 1 |
Jovanovic, N | 1 |
Vukelja, D | 1 |
Medved, V | 1 |
Hotujac, L | 1 |
Sakushima, K | 1 |
Tsuji, S | 1 |
Niino, M | 1 |
Yabe, I | 1 |
Sasaki, H | 1 |
Wolf, A | 1 |
Hutcheson, KA | 1 |
Parentin, F | 1 |
Marchetti, F | 1 |
Faleschini, E | 1 |
Tonini, G | 1 |
Pensiero, S | 1 |
Mowl, AD | 1 |
Grogg, JA | 1 |
Klein, J | 1 |
Wilkes, BN | 1 |
Siatkowski, RM | 3 |
Kiehna, EN | 1 |
Keil, M | 1 |
Lodish, M | 1 |
Stratakis, C | 1 |
Oldfield, EH | 1 |
Lamirel, C | 1 |
Newman, N | 1 |
Biousse, V | 1 |
Mouzaki, M | 1 |
Nichter, C | 1 |
Qureshi, M | 1 |
Rountree, B | 1 |
Furuya, KN | 1 |
Durán, J | 1 |
Jurado, M | 1 |
Jacobelli, S | 1 |
Eymin, G | 1 |
Castiglione, E | 1 |
Valenzuela, R | 1 |
Gutiérrez, MA | 1 |
Battaglia, F | 1 |
Franques, J | 1 |
Somma-Mauvais, H | 1 |
Roche, PH | 1 |
Skau, M | 1 |
Sander, B | 1 |
Milea, D | 1 |
Jensen, R | 1 |
Duclos, C | 1 |
Bonnin, N | 1 |
Merlin, E | 1 |
Viorel, A | 1 |
Lacombe, P | 1 |
Dalens, H | 1 |
Chiambaretta, F | 1 |
Deméocq, F | 1 |
Chazal, J | 1 |
Kanold, J | 1 |
Fraser, C | 1 |
Plant, GT | 1 |
Ball, AK | 1 |
Howman, A | 1 |
Wheatley, K | 1 |
Burdon, MA | 1 |
Matthews, T | 1 |
Jacks, AS | 1 |
Lawden, M | 1 |
Sivaguru, A | 1 |
Furmston, A | 1 |
Howell, S | 1 |
Sharrack, B | 1 |
Davies, MB | 1 |
Clarke, CE | 1 |
Dessardo, NS | 1 |
Dessardo, S | 1 |
Sasso, A | 1 |
Sarunić, AV | 1 |
Dezulović, MS | 1 |
Patiroglu, T | 1 |
Ozcan, A | 1 |
Karakukcu, M | 1 |
Ozdemir, MA | 1 |
Poyrazoglu, G | 1 |
Canpolat, M | 2 |
Unal, E | 1 |
Kaeser, PF | 1 |
Borruat, FX | 1 |
Kang, HM | 1 |
Kim, HY | 1 |
Hacifazlioglu Eldes, N | 1 |
Yilmaz, Y | 1 |
Dolinsky, DH | 1 |
Armstrong, S | 1 |
Martínez-Varea, A | 1 |
Diago-Almela, VJ | 1 |
Abad-Carrascosa, A | 1 |
Perales-Marín, A | 1 |
Skone, K | 1 |
Abbott, J | 1 |
Wacogne, ID | 1 |
Falardeau, J | 2 |
Lobb, BM | 1 |
Golden, S | 1 |
Maxfield, SD | 1 |
Williams, MW | 1 |
Vishwanath, M | 1 |
Göbel, H | 1 |
Göbel, C | 1 |
Heinze, A | 1 |
Per, H | 1 |
Gümüş, H | 1 |
Poyrazoğlu, HG | 1 |
Yıkılmaz, A | 1 |
Karaküçük, S | 1 |
Doğan, H | 1 |
Kumandaş, S | 1 |
Yang, L | 1 |
Hashemi, N | 1 |
Lee, IJ | 1 |
Maccheron, LJ | 1 |
Kwan, AS | 1 |
Lochner, P | 1 |
Nardone, R | 1 |
Tezzon, F | 1 |
Coppo, L | 1 |
Brigo, F | 1 |
Victorio, MC | 1 |
Rothner, AD | 1 |
Villain, MA | 1 |
Pageaux, GP | 1 |
Veyrac, M | 1 |
Arnaud, B | 2 |
Harris, A | 1 |
Greenfield, DS | 2 |
Jeng, MR | 1 |
Rieman, M | 1 |
Bhakta, M | 1 |
Helton, K | 1 |
Wang, WC | 1 |
Kling, F | 1 |
Cochener, B | 1 |
Colin, J | 1 |
Langford, CM | 1 |
Arsava, EM | 1 |
Uluc, K | 1 |
Nurlu, G | 1 |
Kansu, T | 1 |
Nazir, SA | 1 |
Onwuchekwa, AC | 1 |
Nwankwo, CN | 1 |
Chapp-Jumbo, EN | 1 |
STARR, HJ | 1 |
Mathews, MK | 1 |
Savino, PJ | 1 |
Cellucci, T | 1 |
Lee, L | 1 |
Juurlink, DN | 1 |
Frost, N | 1 |
Sweeney, P | 1 |
Pless, M | 1 |
Capozzoli, T | 1 |
Warner, JE | 1 |
Katz, BJ | 1 |
Malomo, AO | 1 |
Idowu, OE | 1 |
Shokunbi, MT | 1 |
Nwaorgu, OG | 1 |
Oluleye, TS | 1 |
Segal, L | 1 |
Discepola, M | 1 |
Wendel, L | 1 |
Boldt, HC | 1 |
Stiebel-Kalish, H | 1 |
Kalish, Y | 1 |
Lusky, M | 1 |
Gaton, DD | 1 |
Ehrlich, R | 1 |
Shuper, A | 1 |
Stevens, SA | 1 |
Previte, M | 1 |
Lakin, WD | 1 |
Thakore, NJ | 1 |
Penar, PL | 1 |
Hamschin, B | 1 |
Esmaili, N | 1 |
Bradfield, YS | 1 |
Brackmann, DE | 1 |
Doherty, JK | 1 |
Sirin, H | 1 |
Akyürekli, O | 1 |
Jamerson, SC | 1 |
Arunagiri, G | 1 |
Ellis, BD | 1 |
Leys, MJ | 1 |
Matthews, YY | 1 |
Jonas, JB | 1 |
Pfeil, K | 1 |
Chatzikonstantinou, A | 1 |
Rensch, F | 1 |
Bassan, H | 1 |
Berkner, L | 1 |
Stolovitch, C | 1 |
Parness-Yossifon, R | 1 |
Margalit, D | 1 |
Pollack, A | 1 |
Leiba, H | 1 |
Machner, B | 1 |
Neppert, B | 1 |
Paulsen, M | 1 |
Hofmann, C | 1 |
Sander, T | 1 |
Helmchen, C | 1 |
Millet, A | 1 |
Nichelli, P | 1 |
Penne, A | 1 |
Gilman, JK | 1 |
Smith, CH | 1 |
Davis, CE | 1 |
Hibri, N | 1 |
Press, OW | 1 |
Ladenson, PW | 1 |
Rostotskaia, VI | 1 |
Lebedev, BV | 1 |
Simernitskiĭ, BP | 1 |
Morozova, NA | 1 |
Brodsky, MC | 1 |
Glasier, CM | 1 |
Wandstrat, TL | 1 |
Phillips, J | 1 |
Campos, SP | 1 |
Olitsky, S | 1 |
Weller, B | 1 |
Sharf, B | 1 |
Sierpinski-Barth, J | 1 |
Schwartz, M | 1 |
Schoeman, JF | 1 |
Glaser, JS | 3 |
Schatz, NJ | 2 |
Hughes, TA | 1 |
Smith, PE | 1 |
McQueen, IN | 1 |
Scanlon, MF | 1 |
Selky, AK | 1 |
Dobyns, WB | 1 |
Yee, RD | 1 |
Hanson, L | 1 |
Morgan, HJ | 1 |
Getenet, JC | 1 |
Croisile, B | 1 |
Vighetto, A | 1 |
Grochowicki, M | 1 |
Goudable, B | 1 |
Aimard, G | 1 |
Trillet, M | 1 |
Mokri, B | 1 |
Jack, CR | 1 |
Petty, GW | 1 |
Korzets, A | 1 |
Gafter, U | 1 |
Floru, S | 1 |
Chagnac, A | 1 |
Zevin, D | 1 |
Traverso, F | 1 |
Stagnaro, R | 1 |
Fazio, B | 1 |
Mathew, NT | 1 |
Ravishankar, K | 1 |
Sanin, LC | 1 |
Huff, AL | 1 |
Hupp, SL | 1 |
Rothrock, JF | 1 |
Winner, P | 1 |
Bello, L | 1 |
Wanichwecharungruang, B | 1 |
Liebmann, JM | 1 |
Ritch, R | 1 |
Goh, KY | 1 |
Krishna, R | 1 |
Kosmorsky, GS | 1 |
Wright, KW | 1 |
Heckmann, JG | 1 |
Niedermeier, W | 1 |
Neundörfer, B | 1 |
Kan, L | 1 |
Sood, SK | 1 |
Maytal, J | 1 |
Keren, T | 1 |
Lahat, E | 1 |
Madsen, RW | 1 |
March, GA | 1 |
Lorrot, M | 1 |
Bader-Meunier, B | 1 |
Sébire, G | 1 |
Dommergues, JP | 1 |
Cinciripini, GS | 1 |
Donahue, S | 1 |
Borchert, MS | 1 |
Quinn, AG | 1 |
Singer, SB | 1 |
Buncic, JR | 1 |
Fort, JA | 1 |
Smith, LD | 1 |
Keiper, GL | 1 |
Sherman, JD | 1 |
Tomsick, TA | 1 |
Tew, JM | 1 |
Villain, M | 1 |
Candon, E | 1 |
Adenis, JP | 1 |
Frerebeau, P | 1 |
Pomeranz, HD | 1 |
Halevy, A | 1 |
Offer, I | 1 |
Garty, B | 1 |
Jakobczyk-Zmija, MJ | 1 |
Spraul, CW | 1 |
Lang, GK | 1 |
Jiménez Moya , AI | 1 |
Ayala Curiel , J | 1 |
Gracia Remiro , R | 1 |
Herrera Martín , M | 1 |
Santana Rodríguez , C | 1 |
Hortelano López , M | 1 |
Romero Escos , D | 1 |
Lorberboym, M | 1 |
Lampl, Y | 2 |
Sadeh, M | 2 |
Gadot, N | 2 |
Weese-Mayer, DE | 1 |
Yang, RJ | 1 |
Mayer, JR | 1 |
Zaparackas, Z | 1 |
Bandyopadhyay, S | 2 |
Sinclair, N | 1 |
Assaad, N | 1 |
Johnston, I | 1 |
Meyer-Heim, A | 1 |
Boltshauser, E | 1 |
Golnik, K | 1 |
Eggenberger, E | 1 |
Yedavally, S | 1 |
Lorberboyn, M | 1 |
Jacobson, DM | 1 |
Leonen, KE | 1 |
Weig, SG | 1 |
Ansari, I | 1 |
Crichlow, B | 1 |
Gunton, KB | 1 |
Diamond, GR | 1 |
Melvin, J | 1 |
Vassilouthis, J | 1 |
Uttley, D | 1 |
Strominger, MB | 1 |
Weiss, GB | 1 |
Mehler, MF | 1 |
Fox, GM | 1 |
Killer, HE | 1 |
Blumer, B | 1 |
Burde, RM | 1 |
Zeller, R | 1 |
Benz, J | 1 |
Holl, K | 1 |
Heissler, HE | 1 |
Nemati, N | 1 |
Gaab, MR | 1 |
Haubitz, B | 1 |
Becker, H | 1 |
To, KW | 1 |
Warren, FA | 1 |
Zachariah, SB | 1 |
Jimenez, L | 1 |
Zachariah, B | 1 |
Prockop, LD | 1 |
Kidron, D | 1 |
Pomeranz, S | 1 |
Katz, VL | 1 |
Peterson, R | 1 |
Cefalo, RC | 1 |
Landan, I | 1 |
Policherla, H | 1 |
McLaurin, J | 1 |
Sørensen, PS | 1 |
Thomsen, AM | 1 |
Gjerris, F | 1 |
Bowman, MA | 1 |
Amacher, AL | 1 |
Spence, JD | 1 |
Raucher, HS | 1 |
Kaufman, DM | 1 |
Goldfarb, J | 1 |
Jacobson, RI | 1 |
Roseman, B | 1 |
Wolff, RR | 1 |
Guidetti, B | 1 |
Giuffrè, R | 1 |
Gambacorta, D | 1 |
Sharma, DB | 1 |
James, A | 1 |
Venable, HP | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Multicenter, Double-blind, Randomized, Placebo-controlled Study of Weight-Reduction and/or Low Sodium Diet Plus Acetazolamide vs Diet Plus Placebo in Subjects With Idiopathic Intracranial Hypertension With Mild Visual Loss[NCT01003639] | Phase 2/Phase 3 | 165 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
Neurocognitive Outcome in Children Who Suffered From Idiopathic Increased Intracranial Hypertension (IIH)[NCT02857335] | 15 participants (Actual) | Interventional | 2016-01-31 | Active, not recruiting | |||
Acetazolamide for Treating NPH in Shunt-candidates Patients: an Open Label Feasibility Trial[NCT03779594] | Phase 2 | 15 participants (Anticipated) | Interventional | 2018-12-31 | Recruiting | ||
Novel Compliant Scaffold With Specific Design for the Treatment of Non-thrombotic Stenosis of Internal Jugular Veins in Patients With Chronic Headache Poor Responder to Best Medical Therapy[NCT04352218] | Phase 2 | 60 participants (Anticipated) | Interventional | 2020-09-30 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Treatment Effects on the Primary Outcome Variable, Mean change From Baseline to Month 6 in Perimetric Mean Deviation (PMD) in the Study Eye. Perimetric mean deviation is a measure of global visual field loss (mean deviation from age-corrected normal values), with a range of 2 to -32 dB; larger negative values indicate greater vision loss. (NCT01003639)
Timeframe: base line and 6 months
Intervention | dB (Mean) |
---|---|
Acetazolamide | 1.43 |
Sugar Pill | 0.71 |
Mean change at month 6 as compared to baseline. Frisén papilledema grade is an ordinal scale that uses ocular fundus features to rate the severity of papilledema; grade 0 indicates no features of papilledema and grade 5 indicates severe papilledema. (NCT01003639)
Timeframe: Baseline and 6 Months
Intervention | units on a scale (Mean) | |
---|---|---|
Study eye | Fellow eye | |
Acetazolamide | -1.31 | -1.14 |
Sugar Pill | -0.61 | -0.52 |
(NCT01003639)
Timeframe: Baseline
Intervention | correct letters (Mean) | |
---|---|---|
Study Eye | Fellow Eye | |
Acetazolamide | 56.8 | 58.3 |
Sugar Pill | 55.6 | 56.2 |
Visual Function Questionnaire (VFQ-25) total score, VFQ-25 10-item neuro-ophthalmic supplement total score: 0-100 (higher scores indicate better quality of life) (NCT01003639)
Timeframe: baseline
Intervention | units on a scale (Mean) | |
---|---|---|
Total score | 10-item neuro-ophthalmic supplement | |
Acetazolamide | 83.8 | 75.8 |
Sugar Pill | 82.1 | 75.0 |
27 reviews available for acetazolamide and Pseudotumor Cerebri
Article | Year |
---|---|
Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Combined Modality Therapy; C | 2021 |
Update on Idiopathic Intracranial Hypertension Management.
Topics: Acetazolamide; Headache; Humans; Intracranial Hypertension; Obesity; Pseudotumor Cerebri; Vision Dis | 2022 |
Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
Topics: Acetazolamide; Female; Headache; Humans; Intracranial Hypertension; Intracranial Pressure; Pseudotum | 2023 |
Brief report: Metabolic acidosis in newborn infants following maternal use of acetazolamide during pregnancy.
Topics: Acetazolamide; Acidosis; Carbonic Anhydrase Inhibitors; Female; Humans; Infant, Newborn; Infant, New | 2020 |
Diagnosis and treatment of idiopathic intracranial hypertension.
Topics: Acetazolamide; Analgesics; Headache; Headache Disorders; Humans; Intracranial Hypertension; Migraine | 2021 |
Should Acetazolamide Be the First-Line Treatment for Patients With Idiopathic Intracranial Hypertension?
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Decision Making; Humans; Intracranial Pressure; Magnet | 2017 |
The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Humans; Multicenter Studies as Topic; Pseudotumor Cere | 2017 |
Pediatric Intracranial Hypertension: a Current Literature Review.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Child; Early Diagnosis; Humans; Pseudotumor Cerebri; Q | 2018 |
An update of idiopathic intracranial hypertension.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Humans; Intracranial Pressure; Papilledema; Pseudotumo | 2018 |
[Idiopathic intracranial hypertension - Swedish consensus guidelines].
Topics: Acetazolamide; Bariatric Surgery; Carbonic Anhydrase Inhibitors; Consensus; Critical Pathways; Diagn | 2019 |
Idiopathic intracranial hypertension and pregnancy.
Topics: Acetazolamide; Diuretics; Female; Humans; Incidence; Pregnancy; Pregnancy Complications, Cardiovascu | 2013 |
[Idiopathic intracranial hypertension and factor V Leiden mutation].
Topics: Acetazolamide; Activated Protein C Resistance; Brain Ischemia; Factor V; Humans; Magnetic Resonance | 2014 |
Headache and the pseudotumor cerebri syndrome.
Topics: Acetazolamide; Back Pain; Diagnosis, Differential; Diuretics; Fructose; Furosemide; Headache Disorde | 2014 |
Acetazolamide for the treatment of idiopathic intracranial hypertension.
Topics: Acetazolamide; Animals; Brain; Carbonic Anhydrase Inhibitors; Humans; Pseudotumor Cerebri | 2015 |
[Characteristic neurological features, differential diagnostic criteria and medicinal treatment of idiopathic intracranial hypertension].
Topics: Acetazolamide; Cerebrospinal Fluid Shunts; Combined Modality Therapy; Diagnosis, Differential; Fruct | 2015 |
Pediatric pseudotumor cerebri.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Pressure; Child; Humans; Magnetic | 2016 |
Update on Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Diuretics; Humans; Papilledema; Pseudotumor Cerebri; Randomized Controlled Trials as | 2017 |
[Idiopathic intracranial hypertension].
Topics: Acetazolamide; Blindness; Combined Modality Therapy; Diagnosis, Differential; Diet Therapy; Evidence | 2017 |
Advances in evaluation and management of pediatric idiopathic intracranial hypertension.
Topics: Acetazolamide; Cerebrospinal Fluid Shunts; Child, Preschool; Female; Humans; Infant; Intracranial Pr | 2008 |
The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension.
Topics: Acetazolamide; Body Mass Index; Carbonic Anhydrase Inhibitors; Constriction, Pathologic; Humans; Int | 2011 |
[Headache from increased cerebrospinal fluid pressure].
Topics: Acetazolamide; Algorithms; Cerebrospinal Fluid Pressure; Cerebrospinal Fluid Shunts; Combined Modali | 2012 |
Diagnosis and treatment of idiopathic intracranial hypertension (IIH) in children and adolescents.
Topics: Acetazolamide; Adolescent; Cerebrospinal Fluid Shunts; Child; Diuretics; Headache; Humans; Intracran | 2013 |
Pseudotumor cerebri.
Topics: Acetazolamide; Adrenal Cortex Hormones; Carbonic Anhydrase Inhibitors; Diagnosis, Differential; Huma | 2003 |
Drugs used in childhood idiopathic or benign intracranial hypertension.
Topics: Acetazolamide; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Carbonic Anhydrase Inhibitors; Cer | 2008 |
[Effect of osmotic diuretics, enzyme-inhibiting diuretics and neuroleptics on cerebral perfusion pressure].
Topics: Acetazolamide; Adrenal Cortex Hormones; Animals; Antipsychotic Agents; Brain Edema; Brain Injuries; | 1983 |
Idiopathic intracranial hypertension after L-thyroxine therapy for acquired primary hypothyroidism.
Topics: Acetazolamide; Child; Dose-Response Relationship, Drug; Female; Humans; Hypothyroidism; Pseudotumor | 1995 |
Pseudotumor cerebri in Lyme disease: a case report and literature review.
Topics: Abducens Nerve; Acetazolamide; Borrelia burgdorferi Group; Carbonic Anhydrase Inhibitors; Ceftriaxon | 1998 |
21 trials available for acetazolamide and Pseudotumor Cerebri
Article | Year |
---|---|
Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adult; Arterioles; Blood Pressure; Carbonic Anhydrase Inhibitors; Diet Therapy; Doubl | 2020 |
Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Pressure; Female; Follow-Up | 2017 |
The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid; Double-Blind Method; Femal | 2018 |
Magnetic resonance imaging finding of empty sella in obesity related idiopathic intracranial hypertension is associated with enlarged sella turcica.
Topics: Acetazolamide; Adult; Diuretics; Female; Humans; Hypertrophy; Magnetic Resonance Imaging; Male; Obes | 2013 |
The idiopathic intracranial hypertension treatment trial: design considerations and methods.
Topics: Acetazolamide; Adolescent; Adult; Antihypertensive Agents; Cerebrospinal Fluid Pressure; Double-Blin | 2014 |
Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Nerve | 2015 |
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Combined Modality Therapy; Diet, So | 2016 |
Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Combined Modality Therapy; Diet, So | 2016 |
Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Humans; | 2016 |
Pseudotumor cerebri: What We Have Learned from the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adolescent; Adult; Diuretics; Female; Humans; Male; Middle Aged; North America; Obesi | 2016 |
Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Female; Follow-Up Studies; Humans; | 2016 |
Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial.
Topics: Acetazolamide; Adult; Anticonvulsants; Carotenoids; Chromatography, High Pressure Liquid; Chromatogr | 2017 |
The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Choroid; Dose-Response Relationship, Drug; Follow-Up S | 2017 |
The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Dose-Response Relationshi | 2017 |
Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Pressure; Combined Modality | 2017 |
Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study.
Topics: Acetazolamide; Adult; Body Mass Index; Diuretics; Female; Follow-Up Studies; Humans; Male; Papillede | 2011 |
A randomised controlled trial of treatment for idiopathic intracranial hypertension.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Male; Middle | 2011 |
Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.
Topics: Acetazolamide; Adolescent; Adult; Anticonvulsants; Body Weight; Carbonic Anhydrase Inhibitors; Cereb | 2007 |
Behavioral disorders in children with idiopathic intracranial hypertension.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Child Behavior Disorders; Follow-Up | 2008 |
The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri)
Topics: Acetazolamide; Adult; Body Mass Index; Body Weight; Female; Humans; Middle Aged; Obesity; Papilledem | 1998 |
Cerebrovascular reactivity in patients under long-term acetazolamide treatment.
Topics: Acetazolamide; Adolescent; Adult; Anticonvulsants; Blood Flow Velocity; Cerebral Arteries; Cerebrova | 2002 |
174 other studies available for acetazolamide and Pseudotumor Cerebri
Article | Year |
---|---|
Recurrent Intracranial Hypertension in a Toddler with Graves' Disease.
Topics: Acetazolamide; Child, Preschool; Female; Graves Disease; Humans; Infant; Intracranial Hypertension; | 2022 |
Managing idiopathic intracranial hypertension in pregnancy: practical advice.
Topics: Acetazolamide; Female; Humans; Intracranial Hypertension; Obesity; Pregnancy; Pseudotumor Cerebri; W | 2022 |
Predictive Value of International Classification of Diseases Codes for Idiopathic Intracranial Hypertension in a University Health System.
Topics: Acetazolamide; Humans; International Classification of Diseases; Pseudotumor Cerebri; Retrospective | 2022 |
The Effect of Optic Nerve Sheath Fenestration on Intraocular Pressure in Patients With Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Eye Diseases; Humans; Intraocular Pressure; Optic Nerve; Pseudotumor Cerebri; Retrosp | 2022 |
Dural Venous Sinus Stenting in Idiopathic Intracranial Hypertension: A National Database Study of 541 Patients.
Topics: Acetazolamide; Cranial Sinuses; Dizziness; Female; Headache; Humans; Intracranial Hypertension; Male | 2022 |
The search for a unifying diagnosis involving neurological, endocrine and immune dysfunction: a case report of a novel presentation of DAVID syndrome.
Topics: Acetazolamide; Adrenocorticotropic Hormone; Child; Child, Preschool; Female; Humans; Hydrocortisone; | 2022 |
The search for a unifying diagnosis involving neurological, endocrine and immune dysfunction: a case report of a novel presentation of DAVID syndrome.
Topics: Acetazolamide; Adrenocorticotropic Hormone; Child; Child, Preschool; Female; Humans; Hydrocortisone; | 2022 |
The search for a unifying diagnosis involving neurological, endocrine and immune dysfunction: a case report of a novel presentation of DAVID syndrome.
Topics: Acetazolamide; Adrenocorticotropic Hormone; Child; Child, Preschool; Female; Humans; Hydrocortisone; | 2022 |
The search for a unifying diagnosis involving neurological, endocrine and immune dysfunction: a case report of a novel presentation of DAVID syndrome.
Topics: Acetazolamide; Adrenocorticotropic Hormone; Child; Child, Preschool; Female; Humans; Hydrocortisone; | 2022 |
Optic nerve sheath diameter correlates to intracranial pressure in spontaneous CSF leak patients.
Topics: Acetazolamide; Adult; Aged; Female; Humans; Intracranial Hypertension; Intracranial Pressure; Middle | 2023 |
Dural Venous Sinus Stent Placement Reduces Dosage Requirements for Carbonic Anhydrase Inhibitors in Patients with Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Humans; Pseudotumor Cerebri; Retrospective Stud | 2023 |
Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension.
Topics: Acetazolamide; Acidosis; Adult; COVID-19; Female; Humans; Pandemics; Pseudotumor Cerebri | 2023 |
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Headache; H | 2023 |
The manifestations of metabolic acidosis during acetazolamide treatment in a cohort of pediatric idiopathic intracranial hypertension.
Topics: Acetazolamide; Acidosis; Carbonic Anhydrase Inhibitors; Child; Humans; Pseudotumor Cerebri; Retrospe | 2024 |
Magnetic Resonance Imaging of Idiopathic Intracranial Hypertension: Before and After Treatment.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Magnetic Resonance Imaging; Pap | 2019 |
Respiratory Complications Associated With Acetazolamide Use in the Management of Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Acidosis; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Middle Aged; Pseudotu | 2019 |
BARIATRIC SURGERY AS A TREATMENT FOR IDIOPATHIC INTRACRANIAL HYPERTENSION IN A MALE ADOLESCENT: CASE REPORT.
Topics: Acetazolamide; Adolescent; Aftercare; Bariatric Surgery; Diuretics; Fundus Oculi; Headache; Humans; | 2020 |
Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Shunts; Cohort Studies; Dip | 2020 |
"More Guts Than Brains?"-The Role of Gut Microbiota in Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Brain; Female; Gastrointestinal Microbiome; Humans; Obesity; Papilledema; Pseudotumor | 2022 |
Changes in intracranial venous hemodynamics in a patient with idiopathic intracranial hypertension after lumbar puncture precedes therapeutic success.
Topics: Acetazolamide; Adult; Brain; Carbonic Anhydrase Inhibitors; Diagnosis, Differential; Female; Hemodyn | 2018 |
Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Algorithms; Atrophy; Carbonic Anhydrase Inhibitors; Case-Control Studies; Dise | 2017 |
Treatment Response in Pediatric Patients With Pseudotumor Cerebri Syndrome.
Topics: Acetazolamide; Adolescent; Brain; Child; Child, Preschool; Diuretics; Drug Therapy, Combination; Fem | 2017 |
Pseudotumor cerebri syndrome in a patient with narcolepsy type 1.
Topics: Acetazolamide; Adolescent; Female; Humans; Narcolepsy; Pseudotumor Cerebri | 2018 |
The importance of specific rehabilitation for an obese patient with idiopathic intracranial hypertension: a case report.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Diet, Reducing; Female; Humans; Obesity; Papill | 2018 |
Successful desensitization in a pediatric patient with acetazolamide allergy.
Topics: Acetazolamide; Adolescent; Anaphylaxis; Anticonvulsants; Desensitization, Immunologic; Drug Hypersen | 2018 |
Giant arachnoid granulation in a child with benign intracranial hypertension: an unusual case.
Topics: Acetazolamide; Arachnoid; Child; Diuretics; Female; Humans; Pseudotumor Cerebri | 2018 |
[Successful treatment with topiramate in a case of idiopathic intracranial hypertension refractory to acetazolamide].
Topics: Acetazolamide; Child; Female; Humans; Magnetic Resonance Imaging; Pseudotumor Cerebri; Treatment Out | 2017 |
Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Diuretics; Drug Therapy, Combinatio | 2019 |
Co-occurrence of acute ophthalmoplegia (without ataxia) and idiopathic intracranial hypertension.
Topics: Abducens Nerve Diseases; Acetazolamide; Acute Disease; Administration, Oral; Adult; Ataxia; Autoanti | 2019 |
Short-term Optic Disc Cupping Reversal in a Patient With Mild Juvenile Open-angle Glaucoma Due to Early Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diet, Reducing; Female; Glaucoma, Open-Angle; Humans; | 2019 |
Pseudotumor cerebri in childhood and adolescence: data from a specialized service.
Topics: Acetazolamide; Adolescent; Child; Child, Preschool; Female; Headache; Humans; Male; Papilledema; Pse | 2018 |
The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Cerebrospinal Fluid Pressure; Femal | 2019 |
Management of Peripapillary Choroidal Neovascular Membrane in Patients With Idiopathic Intracranial Hypertension.
Topics: Acetazolamide; Adolescent; Adult; Angiogenesis Inhibitors; Carbonic Anhydrase Inhibitors; Choroidal | 2019 |
Idiopathic intracranial hypertension presenting with isolated unilateral facial nerve palsy: a case report.
Topics: Acetazolamide; Adult; Facial Paralysis; Female; Headache; Humans; Magnetic Resonance Imaging; Obesit | 2019 |
Idiopathic intracranial hypertension: Are there predictors for visual outcome or recurrences?
Topics: Acetazolamide; Adult; Female; Humans; Hypertension; Intracranial Pressure; Male; Middle Aged; Pseudo | 2019 |
Pseudotumor cerebri induced by topical application of steroid: a case report.
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents; Anticonvulsants; Humans; Hydrocortisone; Male; Progn | 2019 |
[Idiopathic intracranial hypertension is a rare cause of headache in children].
Topics: Acetazolamide; Child, Preschool; Diuretics; Headache; Humans; Male; Papilledema; Pseudotumor Cerebri | 2013 |
Acetazolamide induced severe hepatotoxicity.
Topics: Acetazolamide; Adult; Chemical and Drug Induced Liver Injury; Diuretics; Female; Humans; Jaundice; P | 2013 |
Pseudotumor cerebri in childhood and adolescence -- results of a Germany-wide ESPED-survey.
Topics: Acetazolamide; Adolescent; Age Factors; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Comorbi | 2013 |
Unilateral papilledema in pseudotumor cerebri.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Intracranial Pressure; Obesity; | 2013 |
Viral-induced intracranial hypertension mimicking pseudotumor cerebri.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Central Nervous System Viral Diseases; Child; Child, Pre | 2013 |
[Benign intracranial hypertension secondary to hypoparathyroidism].
Topics: Acetazolamide; Adult; Calcitriol; Calcium Carbonate; Female; Headache; Humans; Hypocalcemia; Hypopar | 2014 |
Intracranial idiopathic hypertension: 1-year follow-up study.
Topics: Acetazolamide; Adult; Body Mass Index; Carbonic Anhydrase Inhibitors; Diagnostic Techniques, Ophthal | 2014 |
[Familial idiopathic intracranial hypertension: two paediatric case reports].
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Female; Genetic Predisposition to D | 2014 |
Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Optic Nerve Diseases; Overweigh | 2014 |
Idiopathic intracranial hypertension.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diet, Sodium-Restricted; Female; Humans; Male; Pseudot | 2014 |
Idiopathic intracranial hypertension--reply.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diet, Sodium-Restricted; Female; Humans; Male; Pseudot | 2014 |
Papilledema associated with puberty.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Child; Diagnosis, Differential; Female; Headache; Huma | 2015 |
Primary pseudotumor cerebri syndrome in a young obese African woman.
Topics: Acetazolamide; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Antihypertensive Agents; Diuretic | 2014 |
[Pseudotumor cerebri in children with sickle cell disease].
Topics: Abducens Nerve Diseases; Acetazolamide; Adolescent; Anemia, Sickle Cell; Diplopia; Female; Headache; | 2015 |
[Intracranial hypertension and jugular vein thrombosis].
Topics: Acetazolamide; Adult; Anticoagulants; Carbonic Anhydrase Inhibitors; Coumarins; Diagnosis, Different | 2015 |
Acetazolamide-Induced Nephrolithiasis in Idiopathic Intracranial Hypertension Patients.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Case-Control Studies; Female; Follow-Up Studies | 2016 |
Idiopathic intracranial hypertension presenting as postpartum headache.
Topics: Acetazolamide; Adult; Cerebral Veins; Diet, Sodium-Restricted; Diuretics; Female; Headache Disorders | 2016 |
A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
Topics: Acetazolamide; Adult; Anticonvulsants; Endovascular Procedures; Female; Follow-Up Studies; Headache; | 2017 |
The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Clinical Trials as Topic; Humans; Pseudotumor Cerebri; | 2016 |
Guiding follow-up of paediatric idiopathic intracranial hypertension with optical coherence tomography.
Topics: Acetazolamide; Adolescent; Child; Diuretics; Female; Follow-Up Studies; Humans; Papilledema; Pseudot | 2016 |
Possible association between acetazolamide administration during pregnancy and multiple congenital malformations.
Topics: Abnormalities, Multiple; Acetazolamide; Child; Female; Humans; Limb Deformities, Congenital; Male; P | 2016 |
Presumed Pseudotumor Cerebri Syndrome After Withdrawal of Inhaled Glucocorticoids.
Topics: Acetazolamide; Administration, Inhalation; Asthma; Child; Diplopia; Female; Glucocorticoids; Growth; | 2016 |
Fulminant idiopathic intracranial hypertension managed with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Pseudotum | 2016 |
Normal Pressure Pseudotumor Cerebri: A Series of Six Patients.
Topics: Acetazolamide; Adult; Cerebrospinal Fluid Pressure; Female; Humans; Intracranial Hypertension; Neuro | 2017 |
Probable pseudotumor cerebri complex in 25 children. Further support of a concept.
Topics: Abducens Nerve Diseases; Acetazolamide; Adolescent; Cerebrospinal Fluid Pressure; Child; Child, Pres | 2017 |
Pseudotumour cerebri in children: Aetiology, clinical features, and progression.
Topics: Acetazolamide; Adolescent; Child; Disease Progression; Female; Humans; Male; Pseudotumor Cerebri; Re | 2019 |
Desensitization to acetazolamide in a patient with previous antimicrobial sulfonamide allergy.
Topics: Acetazolamide; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Desensitization, Immunologic; D | 2017 |
A Young Woman With Headaches and Blurry Vision.
Topics: Acetazolamide; Angiogenesis Inhibitors; Bevacizumab; Carbonic Anhydrase Inhibitors; Choroidal Neovas | 2017 |
Pseudotumor cerebri in pediatric age: role of obesity in the management of neurological impairments.
Topics: Acetazolamide; Adolescent; Cerebrospinal Fluid; Child; Child, Preschool; Cranial Nerve Diseases; Die | 2008 |
Psychiatric symptoms in idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Borderline Personality Disorder; Depersonalization; Diagnosis, Differential; D | 2008 |
[Idiopathic intracranial hypertension without headache detected during a routine health check].
Topics: Acetazolamide; Female; Fundus Oculi; Headache; Humans; Middle Aged; Papilledema; Physical Examinatio | 2008 |
Acute comitant esotropia secondary to idiopathic intracranial hypertension in a child receiving recombinant human growth hormone.
Topics: Acetazolamide; Acute Disease; Child; Dexamethasone; Diplopia; Drug Therapy, Combination; Esotropia; | 2009 |
Secondary pseudotumour cerebri in a patient undergoing sexual reassignment therapy.
Topics: Acetazolamide; Androgens; Diuretics; Drug Administration Schedule; Humans; Injections, Intramuscular | 2009 |
Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
Topics: Acetazolamide; Adolescent; Decompression, Surgical; Disease Progression; Female; Humans; Methylpredn | 2009 |
Pseudotumor cerebri after surgical remission of Cushing's disease.
Topics: Acetazolamide; ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Anti-Inflammatory Agents; Carbon | 2010 |
Choroidal infarction in fulminant idiopathic intracranial hypertension.
Topics: Acetazolamide; Choroid; Choroid Diseases; Diuretics; Female; Headache; Humans; Infarction; Ophthalmi | 2010 |
Idiopathic intracranial hypertension in two patients with Alagille syndrome.
Topics: Acetazolamide; Age of Onset; Alagille Syndrome; Cerebrospinal Fluid Pressure; Child, Preschool; Diur | 2010 |
[Pseudotumor cerebri secondary to Behçet disease. Report of one case].
Topics: Acetazolamide; Adolescent; Behcet Syndrome; Colchicine; Female; Humans; Pseudotumor Cerebri | 2010 |
[Clinical presentation suggesting Bickerstaff encephalitis and intracranial hypertension].
Topics: Acetazolamide; Diuretics; Electroencephalography; Electromyography; Encephalitis; Gait Disorders, Ne | 2011 |
[Benign but not harmless intracranial hypertension: a case report].
Topics: Abducens Nerve Diseases; Acetazolamide; Adolescent; Diplopia; Diuretics; Female; Humans; Meningitis, | 2010 |
Pediatric idiopathic intracranial hypertension: clinical and demographic features.
Topics: Acetazolamide; Adolescent; Child; Diuretics; Female; Humans; Male; Obesity; Ophthalmoscopy; Papilled | 2010 |
Mycophenolate mofetil-induced pseudotumor cerebri in a boy with autoimmune lymphoproliferative disease.
Topics: Acetazolamide; Autoimmune Lymphoproliferative Syndrome; Carbonic Anhydrase Inhibitors; Child, Presch | 2011 |
Peripapillary neovascular membrane: a rare cause of acute vision loss in pediatric idiopathic intracranial hypertension.
Topics: Acetazolamide; Acute Disease; Administration, Oral; Adolescent; Blindness; Cerebrospinal Fluid Press | 2011 |
A case of pediatric idiopathic intracranial hypertension presenting with divergence insufficiency.
Topics: Acetazolamide; Administration, Oral; Child; Diagnosis, Differential; Diuretics; Esotropia; Exotropia | 2011 |
Pseudotumour cerebri in children: etiological, clinical features and treatment modalities.
Topics: Acetazolamide; Adolescent; Anti-Inflammatory Agents; Anticonvulsants; Cerebrospinal Fluid Pressure; | 2012 |
An 8-year-old girl with headache and syncope.
Topics: Acetazolamide; Child; Diuretics; Female; Headache; Humans; Insulin Resistance; Obesity; Pseudotumor | 2011 |
Progressive visual loss in a pregnant woman with idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Female; Humans; Obesity; Pregnancy; Pregnancy Complications; Pseudotumor Cereb | 2012 |
From menorrhagia to manometers.
Topics: Abducens Nerve Diseases; Acetazolamide; Adolescent; Anemia; Coombs Test; Diuretics; Fatigue; Female; | 2012 |
The use of acetazolamide during pregnancy in intracranial hypertension patients.
Topics: Acetazolamide; Adult; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnan | 2013 |
Intracranial hypertension: was it really idiopathic?
Topics: Acetazolamide; Adult; Anticoagulants; Anticonvulsants; Diagnosis, Differential; Drug Therapy, Combin | 2011 |
Clinical spectrum of the pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis.
Topics: Acetazolamide; Adolescent; Age of Onset; Anticonvulsants; Child; Child, Preschool; Female; Humans; I | 2013 |
Intracranial complications of idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Anticoagulants; Cerebral Veins; Drug Therapy, Combination; Female; Humans; Mag | 2012 |
Intravitreal bevacizumab in the treatment of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension.
Topics: Acetazolamide; Adolescent; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; | 2013 |
Optic nerve sonography to monitor treatment efficacy in idiopathic intracranial hypertension: a case report.
Topics: Acetazolamide; Antihypertensive Agents; Combined Modality Therapy; Diet Therapy; Female; Humans; Mid | 2013 |
Effect of acetazolamide on ocular hemodynamics in pseudotumor cerebri associated with inflammatory bowel disease.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Choroid; Crohn Disease; F | 2002 |
Pseudotumor cerebri in two adolescents with acquired aplastic anemia.
Topics: Acetazolamide; Adolescent; Anemia, Aplastic; Anticonvulsants; Brain; Carbonic Anhydrase Inhibitors; | 2002 |
[Bilateral papilledema in young women: two case reports of benign intracranial hypertension?].
Topics: Acetazolamide; Adolescent; Adult; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Female; Fluo | 2002 |
Pseudotumor cerebri in a pre-pubescent child--case report.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Child; Diplopia; Esotropia; Headache; Humans; Intracra | 2002 |
Electrophysiological evidence of trigeminal neuropathy in pseudotumor cerebri.
Topics: Acetazolamide; Adult; Cerebrospinal Fluid Shunts; Female; Humans; Intracranial Hypertension; Neural | 2002 |
Pseudotumor cerebri in idiopathic aplastic anemia.
Topics: Acetazolamide; Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Humans; Male; | 2003 |
A 14-year-old Nigerian female with idiopathic intracranial hypertension (Pseudotumor cerebri or benign intracranial hypertension).
Topics: Acetazolamide; Adolescent; Anticonvulsants; Female; Headache Disorders, Secondary; Humans; Nigeria; | 2002 |
PSEUDOTUMOR CEREBRI. REPORT OF SIX CASES COMPARED WITH ONE CASE OF PSEUDOPAPILLEDEMA.
Topics: Acetazolamide; Brain Diseases; Brain Neoplasms; Chlorothiazide; Diagnosis; Diet, Sodium-Restricted; | 1964 |
The headache of teenage acne.
Topics: Acetazolamide; Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Carbonic Anhydrase Inhibitors; Fema | 2004 |
Myxedema, papilledema, and elevated CSF protein.
Topics: Acetazolamide; Anemia, Pernicious; Cerebrospinal Fluid Proteins; Confusion; Diagnosis, Differential; | 2004 |
The use of acetazolamide in idiopathic intracranial hypertension during pregnancy.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Female; Humans; Pregnancy; Pregnancy Complicati | 2005 |
Metamorphopsia as an initial complaint of idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angiography; Humans; Magnet | 2005 |
Non-operative management of benign intracranial hypertension presenting with complete visual loss and deafness.
Topics: Acetazolamide; Adolescent; Blindness; Deafness; Diuretics; Female; Humans; Niacin; Pseudotumor Cereb | 2006 |
Idiopathic intracranial hypertension and sickle cell disease: two case reports.
Topics: Acetazolamide; Adolescent; Adult; Anemia, Sickle Cell; Carbonic Anhydrase Inhibitors; Female; Headac | 2005 |
Subretinal neovascular membrane in idiopathic intracranial hypertension.
Topics: Acetazolamide; Combined Modality Therapy; Diuretics; Female; Furosemide; Humans; Laser Coagulation; | 2006 |
Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Female; Fo | 2006 |
Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study.
Topics: Acetazolamide; Algorithms; Cerebrospinal Fluid; Cerebrospinal Fluid Pressure; Cerebrovascular Circul | 2007 |
Pseudotumor cerebri in children with Down syndrome.
Topics: Acetazolamide; Child; Child, Preschool; Diuretics; Down Syndrome; Female; Humans; Intracranial Press | 2007 |
Facial palsy and fallopian canal expansion associated with idiopathic intracranial hypertension.
Topics: Acetazolamide; Child; Diagnosis, Differential; Facial Paralysis; Geniculate Ganglion; Hearing Loss, | 2007 |
Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebri.
Topics: Acetazolamide; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Human | 2009 |
Ophthalmodynamometric measurement of central retinal vein pressure as surrogate of intracranial pressure in idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Central Venous Pressure; Cerebrospinal Fluid Pr | 2008 |
Asymptomatic idiopathic intracranial hypertension in children.
Topics: Acetazolamide; Adolescent; Age Factors; Child; Child, Preschool; Diuretics; Female; Humans; Male; Ob | 2008 |
Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia.
Topics: Acetazolamide; Adult; Anticonvulsants; Antineoplastic Agents; Female; Humans; Idarubicin; Leukemia, | 2008 |
Permanent inferior binasal quadrantanopsia in pseudotumor cerebri.
Topics: Acetazolamide; Humans; Male; Middle Aged; Papilledema; Pseudotumor Cerebri; Vision Disorders | 1983 |
Benign intracranial hypertension, monoclonal gammopathy, and superior sagittal sinus thrombosis.
Topics: Acetazolamide; Arm; Cranial Sinuses; Humans; Hypergammaglobulinemia; Immunoglobulin G; Leg; Male; Mi | 1983 |
Pseudotumor cerebri and hypothyroidism.
Topics: Acetazolamide; Adult; Body Weight; Drainage; Female; Glucocorticoids; Humans; Hypothyroidism; Intrac | 1983 |
New and old concepts in sarcoidosis.
Topics: Acetazolamide; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Prednisone; Prop | 1983 |
[Principles and results of treating the hypertension-hydrocephalic syndrome in children].
Topics: Acetazolamide; Adolescent; Child; Child, Preschool; Electroencephalography; Humans; Hydrocephalus; I | 1982 |
Magnetic resonance visualization of the swollen optic disc in papilledema.
Topics: Acetazolamide; Administration, Oral; Child; Diuretics; Fundus Oculi; Gadolinium; Humans; Magnetic Re | 1995 |
Pseudotumor cerebri responsive to acetazolamide.
Topics: Acetazolamide; Adolescent; Dexamethasone; Female; Headache; Humans; Pseudotumor Cerebri; Tetracyclin | 1995 |
[Idiopathic intracranial hypertension and tetracycline].
Topics: Acetazolamide; Adolescent; Adult; Female; Headache; Humans; Male; Papilledema; Pseudotumor Cerebri; | 1994 |
Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series.
Topics: Acetazolamide; Administration, Oral; Adolescent; Child; Child, Preschool; Dose-Response Relationship | 1994 |
High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri.
Topics: Acetazolamide; Acute Disease; Administration, Oral; Adolescent; Adult; Blindness; Drug Therapy, Comb | 1994 |
Leydig cell tumour of the testicle associated with benign intracranial hypertension.
Topics: Acetazolamide; Adult; Feminization; Gonadal Steroid Hormones; Humans; Leydig Cell Tumor; Male; Pitui | 1994 |
Idiopathic intracranial hypertension and facial diplegia.
Topics: Acetazolamide; Adolescent; Diplopia; Facial Nerve; Facial Paralysis; Female; Headache; Humans; Pseud | 1994 |
A young leukemic patient with headache.
Topics: Acetazolamide; Adult; Female; Headache; Humans; Leukemia, Myeloid, Acute; Pseudotumor Cerebri | 1993 |
Idiopathic intracranial hypertension after ofloxacin treatment.
Topics: Acetazolamide; Adult; Femoral Fractures; Humans; Intracranial Pressure; Long-Term Care; Male; Ofloxa | 1993 |
Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies.
Topics: Acetazolamide; Antibodies, Antiphospholipid; Cerebral Angiography; Cerebral Veins; Hearing Loss, Noi | 1993 |
Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri.
Topics: Acetazolamide; Acute Kidney Injury; Adult; Female; Humans; Kidney Transplantation; Pseudotumor Cereb | 1993 |
Benign intracranial hypertension associated with HIV infection.
Topics: Acetazolamide; Adult; AIDS Dementia Complex; Cerebrospinal Fluid Pressure; Female; HIV Seropositivit | 1993 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studie | 1996 |
Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Chronic Disease; Female; Headache; Humans; Intracranial Pressure; Middle Aged; | 1996 |
Idiopathic intracranial hypertension in a young child without visual symptoms or signs.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Child; Headache; Humans; Intracranial Pressure; Male; | 1996 |
Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy.
Topics: Acetazolamide; Adult; Antimetabolites; Carbonic Anhydrase Inhibitors; Female; Fluorouracil; Fundus O | 1997 |
Optic nerve sheath fenestration for pseudotumor cerebri.
Topics: Acetazolamide; Adolescent; Adult; Diuretics; Female; Follow-Up Studies; Humans; Intracranial Pressur | 1997 |
Pseudotumor cerebri sine papilledema with unilateral sixth nerve palsy.
Topics: Abducens Nerve; Acetazolamide; Adolescent; Cranial Nerve Diseases; Diplopia; Female; Headache; Human | 1998 |
[Indications for acetazolamide in neurology].
Topics: Acetazolamide; Brain; Epilepsy; Humans; Pseudotumor Cerebri; Vasodilation | 1998 |
Pseudotumor cerebri as a presenting symptom of acute sinusitis in a child.
Topics: Acetazolamide; Acute Disease; Adolescent; Amoxicillin; Anti-Inflammatory Agents; Drug Therapy, Combi | 1998 |
[Benign intracranial hypertension: an unrecognized complication of corticosteroid therapy].
Topics: Acetazolamide; Administration, Oral; Anti-Inflammatory Agents; Child; Combined Modality Therapy; Diu | 1999 |
Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome.
Topics: Acetazolamide; Cerebrospinal Fluid Pressure; Child; Child, Preschool; Diplopia; Drug Therapy, Combin | 1999 |
Pediatric tetracycline-induced pseudotumor cerbri.
Topics: Acetazolamide; Acne Vulgaris; Adolescent; Anti-Bacterial Agents; Child; Dexamethasone; Diuretics; Dr | 1999 |
Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.
Topics: Acetazolamide; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Child; Cytarabine; | 1999 |
Dural sinus thrombosis and pseudotumor cerebri: unexpected complications of suboccipital craniotomy and translabyrinthine craniectomy.
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents; Cerebrospinal Fluid Shunts; Cerebrovascular Circulat | 1999 |
[Intra-orbital decompression of the optic nerve by opening the peri-optic meninges in the treatment of severe optic neuropathies complicating benign intracranial hypertension].
Topics: Acetazolamide; Adolescent; Adult; Combined Modality Therapy; Decompression, Surgical; Diuretics; Fem | 1999 |
Weight loss, acetazolamide, and pseudotumor cerebri.
Topics: Acetazolamide; Body Weight; Humans; Obesity; Papilledema; Pseudotumor Cerebri; Weight Loss | 1999 |
[Benign intracranial hypertension following minocycline].
Topics: Acetazolamide; Adolescent; Anti-Bacterial Agents; Diuretics; Female; Headache; Humans; Minocycline; | 1998 |
[Distinct papilledema in pseudotumor cerebri in vitamin A hypervitaminosis. A 35-year-old patient with distinct papilledema and double-image perception].
Topics: Acetazolamide; Adult; Anti-Inflammatory Agents; Anticonvulsants; Diplopia; Humans; Hypervitaminosis | 2000 |
[Sigmoid sinus thrombosis as a complication of otitis media].
Topics: Acetazolamide; Acetone; Anti-Infective Agents; Anticonvulsants; Child, Preschool; Female; Follow-Up | 2000 |
Benign intracranial hypertension: correlation of cerebral blood flow with disease severity.
Topics: Acetazolamide; Adult; Brain; Cerebrovascular Circulation; Chronic Disease; Diuretics; Female; Humans | 2001 |
Minocycline and Pseudotumor cerebri: The well-known but well-kept secret.
Topics: Acetazolamide; Acne Vulgaris; Child; Drug Information Services; Drug Labeling; Humans; Internship an | 2001 |
Pseudotumor cerebri.
Topics: Acetazolamide; Adrenal Cortex Hormones; Diagnosis, Differential; Furosemide; Humans; Pseudotumor Cer | 2001 |
Pseudotumour cerebri occurring in association with the Chiari malformation.
Topics: Acetazolamide; Arnold-Chiari Malformation; Child; Female; Humans; Magnetic Resonance Imaging; Pseudo | 2002 |
[Treatment of acne with consequences -- pseudotumor cerebri due to hypervitaminosis A].
Topics: Acetazolamide; Acne Vulgaris; Adolescent; Anticonvulsants; Female; Humans; Pseudotumor Cerebri; Spin | 2002 |
Sleep apnea and intracranial hypertension in men.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Humans; Intracranial Pressure; Male; Middle Age | 2002 |
Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria.
Topics: Acetazolamide; Adult; Age of Onset; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Diuretic | 2002 |
An 18-year-old woman with unexplained vision loss.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Female; Humans; Pseudotumor Cerebri | 2002 |
Asymptomatic idiopathic intracranial hypertension in young children.
Topics: Acetazolamide; Brain; Carbonic Anhydrase Inhibitors; Child, Preschool; Headache; Humans; Male; Papil | 2002 |
A child with venous sinus thrombosis with initial examination findings of pseudotumor syndrome.
Topics: Acetazolamide; Brain; Ceftriaxone; Child; Drug Therapy, Combination; Female; Heparin, Low-Molecular- | 2002 |
Benign intracranial hypertension: clinical features and diagnosis using computed tomography and treatment.
Topics: Acetazolamide; Adolescent; Adult; Child; Dexamethasone; Female; Humans; Male; Middle Aged; Pseudotum | 1979 |
Asymptomatic unilateral papilledema in pseudotumor cerebri.
Topics: Acetazolamide; Adult; Female; Fluorescein Angiography; Fundus Oculi; Humans; Papilledema; Pseudotumo | 1992 |
Visual loss in pseudotumor cerebri from branch retinal artery occlusion.
Topics: Acetazolamide; Adolescent; Blindness; Female; Fundus Oculi; Glucocorticoids; Humans; Papilledema; Ps | 1992 |
[Pseudotumor cerebri, clinical parameters and therapeutic modalities].
Topics: Acetazolamide; Adult; Cerebrospinal Fluid Shunts; Child; Female; Humans; Male; Nerve Compression Syn | 1992 |
[Pseudotumor cerebri in pregnancy].
Topics: Acetazolamide; Adult; Brain Neoplasms; Diagnosis, Differential; Female; Fetal Death; Humans; Pregnan | 1990 |
[The effect of acetazolamide-induced, endogenous volume stress of the cerebrospinal system on intracranial pressure. Diamox--effect on intracranial pressure].
Topics: Acetazolamide; Adolescent; Adult; Blood-Brain Barrier; Cerebrospinal Fluid Shunts; Female; Humans; I | 1990 |
Unilateral papilledema in pseudotumor cerebri.
Topics: Acetazolamide; Female; Fluorescein Angiography; Fundus Oculi; Humans; Middle Aged; Papilledema; Pseu | 1990 |
Pseudotumour cerebri with focal neurological deficit.
Topics: Acetazolamide; Adult; Facial Paralysis; Female; Hemiplegia; Humans; Prednisone; Pseudotumor Cerebri | 1990 |
Malignant pseudotumor cerebri. Report of two cases.
Topics: Acetazolamide; Adolescent; Adult; Cerebrospinal Fluid Pressure; Cerebrospinal Fluid Shunts; Dexameth | 1989 |
Pseudotumor cerebri and pregnancy.
Topics: Acetaminophen; Acetazolamide; Codeine; Female; Furosemide; Humans; Infant, Newborn; Male; Pregnancy; | 1989 |
Pseudotumor cerebri in men.
Topics: Acetazolamide; Adolescent; Adult; Body Weight; Female; Humans; Hypertension; Male; Middle Aged; Obes | 1988 |
Complete external ophthalmoplegia in a case of pseudotumor cerebri.
Topics: Acetazolamide; Adult; Dexamethasone; Female; Humans; Ophthalmoplegia; Pseudotumor Cerebri | 1987 |
Persistent disturbances of cognitive functions in patients with pseudotumor cerebri.
Topics: Acetazolamide; Adolescent; Adult; Cognition Disorders; Female; Follow-Up Studies; Humans; Learning; | 1986 |
Pseudotumor cerebri.
Topics: Acetazolamide; Adult; Atenolol; Cerebrospinal Fluid Shunts; Female; Humans; Intracranial Pressure; P | 1987 |
Spectrum of benign intracranial hypertension in children and adolescents.
Topics: Acetazolamide; Adolescent; Anti-Bacterial Agents; Brain Concussion; Cerebrospinal Fluid Shunts; Chil | 1985 |
Pseudotumor cerebri and Lyme disease: a new association.
Topics: Acetazolamide; Child; Female; Humans; Lyme Disease; Penicillins; Prednisone; Pseudotumor Cerebri | 1985 |
Follow-up study of 100 cases of pseudotumor cerebri.
Topics: Acetazolamide; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Brain Diseases; Child; Child, P | 1968 |
Letter: Benign intracranial hypertension associated with nitrofurantoin therapy.
Topics: Acetazolamide; Cephalometry; Humans; Infant; Male; Nitrofurantoin; Pseudotumor Cerebri | 1974 |
Pseudo-tumor cerebri: further studies.
Topics: Acetazolamide; Adolescent; Adult; Age Factors; Female; Humans; Middle Aged; Pseudotumor Cerebri | 1973 |